Actavis: Still the Trusted Name in U.S. Generics

On March 17, 2015, Actavis combined with another industry giant, Allergan, creating one of the world’s fastest growing, most dynamic pharmaceutical companies in global health care.

While we are excited about our new Allergan corporate name and branding, launched June 15, 2015, we also recognized the tremendous value the Actavis name represents for our generic products in the U.S. This is why Actavis generic products in the U.S. will continue to carry the Actavis name and label!

Our decision to retain the Actavis identity for our U.S. Generics business is based on important feedback from you: our customers. We heard you—and we agree that the Actavis name is an important differentiator for the high-quality, reliable, diverse portfolio of cost-effective generic medicines we provide in the U.S. Our business is now supported by a new website for our generic products in the U.S. at www.Actavis.us. And we continue our work to ensure the best customer experience in the industry.

The hallmarks of our industry-leading customer service commitment include:

• Providing high-quality, affordable generic medicines that enhance access to important treatments
• Remaining the partner of choice for our physicians, specialists, pharmacists, regulators, and patients
• Creating the best customer experience based on deeply held relationships with health care providers
• Unveiling new products that answer market needs, investing approximately $1.7 billion in R&D in 2015

The change of our corporate name to Allergan plc and decision to retain the Actavis name for our U.S. Generics business has no impact on the way our customers interact with us. Learn more about our broad U.S. product portfolio and our commitment to R&D, quality and product safety at www.Actavis.us.

For more information, visit http://www.Actavis.us.